Protara Therapeutics, Inc. (TARA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -21.34M | -16.95M | -12.45M | -12.25M | -14.71M | -9.31M | -8.43M | -7.69M | -10.38M | -8.7M | -6.56M | -9.41M | -12.89M | -5.03M | -5.35M | -5.12M | -10.96M | -6.91M | -6.2M | -9.47M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -45.06% | -82.1% | -47.64% | -59.36% | -41.76% | -6.99% | -28.55% | 18.29% | 19.47% | -73.1% | -22.7% | -83.64% | -17.58% | 27.23% | 13.77% | 45.93% | 8.05% | -2.08% | -64.83% | -65.25% |
| Net Income | -17.78M | -17.31M | -13.26M | -14.96M | -11.91M | -12.77M | -11.22M | -9.51M | -11.1M | -10.22M | -9.86M | -11.29M | -9.04M | -38.97M | -7.69M | -8.54M | -10.76M | -10.23M | -10.78M | -12.78M |
| Depreciation & Amortization | 90K | 93K | 88K | 98K | 83K | 82K | 84K | 83K | 83K | 107K | 107K | 420K | 77K | -949K | 64K | 53K | 56K | 54K | 0 | 55K |
| Stock-Based Compensation | 1.36M | 1.04M | 1.05M | 903K | 833K | 904K | 931K | 1.06M | 1.23M | 1.45M | 1.45M | 0 | 1.57M | 1.43M | 1.44M | 1.94M | 1.88M | 1.91M | 0 | 3M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 93K | -48K | -123K | -99K | 97K | -20K | -77K | 243K | 178K | 189K | 882K | 1.49M | 270K | 30.99M | 614K | 688K | 751K | 457K | 3.54M | 464K |
| Working Capital Changes | -5.11M | -731K | -206K | 1.81M | -3.81M | 2.5M | 1.85M | 436K | -771K | -227K | 1.87M | -19K | -5.76M | 2.47M | 229K | 733K | -2.89M | 902K | 1.04M | -209K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.09M | -1.56M | -795K | 2.99M | -1.5M | 1.52M | 910K | 413K | -1.46M | -70K | 652K | -2.23M | 2.5M | 1.13M | 64K | -149K | -413K | 26K | -475K | -449K |
| Cash from Investing | -14.72M | -26.91M | -6.51M | -47.72M | -58.35M | 22.5M | -29.39M | 2.94M | 23.1M | 14.52M | 6.38M | 22.35M | 9.86M | -18.34M | 19.05M | 13.5M | 745K | 1.89M | 107K | -1.94M |
| Capital Expenditures | 0 | -24K | -4K | -22K | -44K | 0 | -8K | -55K | 0 | 0 | -37K | -2K | -6K | -6K | -83K | -20K | -11K | -44K | 64K | -326K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.14M | 80.96M | 13K | 8K | 1.73M | 97.85M | 0 | 42.09M | -76K | 0 | -27K | 0 | -64K | 0 | -18K | 0 | -72K | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.42M | 80.96M | 13K | 8K | 1.92M | 94.04M | 0 | 42.17M | -76K | 0 | -27K | 0 | -64K | 0 | -18K | 0 | -72K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76K | -76K | 0 | -27K | 0 | -64K | 0 | -18K | 0 | -72K | 0 | 0 | 0 |
| Other Financing | -272K | 0 | 0 | 0 | -185K | 3.81M | 0 | -83K | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -34.92M | 37.11M | -18.95M | -59.97M | -71.34M | 111.04M | -37.82M | 37.35M | 12.64M | 5.82M | -210K | 12.94M | -3.09M | -23.37M | 13.68M | 8.38M | -10.29M | -5.02M | -6.09M | -11.41M |
| Free Cash Flow | -21.34M | -16.97M | -12.46M | -12.27M | -14.76M | -9.31M | -8.44M | -7.74M | -10.38M | -8.7M | -6.6M | -9.41M | -12.89M | -5.03M | -5.43M | -5.14M | -10.97M | -6.95M | -6.14M | -9.8M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -44.63% | -82.36% | -47.55% | -58.51% | -42.18% | -6.99% | -27.95% | 17.73% | 19.51% | -72.89% | -21.51% | -82.97% | -17.52% | 27.61% | 11.52% | 47.52% | 10.14% | 4.48% | -57.6% | -71.11% |
| FCF per Share | -0.50 | -0.37 | -0.29 | -0.29 | -0.36 | -0.35 | -0.38 | -0.36 | -0.91 | -0.77 | -0.58 | -0.83 | -1.14 | -0.45 | -0.48 | -0.46 | -0.98 | -0.62 | -0.55 | -0.87 |
| FCF Conversion (FCF/Net Income) | 1.20x | 0.98x | 0.94x | 0.82x | 1.23x | 0.73x | 0.75x | 0.81x | 0.94x | 0.85x | 0.67x | 0.83x | 1.42x | 0.13x | 0.70x | 0.60x | 1.02x | 0.68x | 0.58x | 0.74x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |